Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Parkner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 8, 2013
Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patientsJ Janukonyté, T Parkner, T Lauritzen, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 20, 2014
Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patientsJ Janukonytė, T Parkner, T Lauritzen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2008
Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetesT Parkner, T Laursen, E T Vestergaard, et al.
European Journal of Clinical Nutrition|February 25, 2011
Do all patients with type 2 diabetes need breakfast?T Parkner, J K Nielsen, T D Sandahl, et al.
Diabetes, Obesity & Metabolism|June 27, 2007
Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetesT Parkner, M K Møller, J W Chen, et al.
Diabetes, Obesity & Metabolism|April 27, 2010
Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetesT Parkner, S E Dyrskog, T Laursen, et al.
Diabetes, Obesity & Metabolism|April 13, 2010
Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolusS B Petersen, J Kildegaard, F S Nielsen, et al.
Diabetologia|March 28, 2012
Soluble CD163: a biomarker linking macrophages and insulin resistanceT Parkner, L P Sørensen, A R Nielsen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 8, 2013
Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patientsJ Janukonyté, T Parkner, T Lauritzen, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 20, 2014
Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patientsJ Janukonytė, T Parkner, T Lauritzen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 2008
Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetesT Parkner, T Laursen, E T Vestergaard, et al.
European Journal of Clinical Nutrition|February 25, 2011
Do all patients with type 2 diabetes need breakfast?T Parkner, J K Nielsen, T D Sandahl, et al.
Diabetes, Obesity & Metabolism|June 27, 2007
Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetesT Parkner, M K Møller, J W Chen, et al.
Diabetes, Obesity & Metabolism|April 27, 2010
Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetesT Parkner, S E Dyrskog, T Laursen, et al.
Diabetes, Obesity & Metabolism|April 13, 2010
Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolusS B Petersen, J Kildegaard, F S Nielsen, et al.
Diabetologia|March 28, 2012
Soluble CD163: a biomarker linking macrophages and insulin resistanceT Parkner, L P Sørensen, A R Nielsen, et al.
Pageof 1